Chargement en cours...
Elbasvir/Grazoprevir: A Review of the Latest Agent in the Fight against Hepatitis C
Hepatitis C virus (HCV) is estimated to affect up to 150 million people worldwide. Despite worldwide prevalence, treatment modalities prior to 2011 remained suboptimal, with low virologic response rates and intolerable side effect profiles. Fortunately, the landscape of treatment for chronic hepatit...
Enregistré dans:
| Publié dans: | Int J Hepatol |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Hindawi Publishing Corporation
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4925941/ https://ncbi.nlm.nih.gov/pubmed/27403342 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/3852126 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|